OMX Stockholm PI
1.007,80
PKT
+10,37
PKT
+1,04
%
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.12.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 11.12.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.12.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 09.12.14 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 09.12.14 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 05.12.14 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 04.12.14 | Nokia overweight | JP Morgan Chase & Co. | |
| 03.12.14 | AstraZeneca Underweight | Morgan Stanley | |
| 01.12.14 | Volvo (B) Hold | Deutsche Bank AG | |
| 01.12.14 | Volvo (B) Outperform | Credit Suisse Group | |
| 26.11.14 | Volvo (B) Underweight | Morgan Stanley | |
| 26.11.14 | AstraZeneca buy | UBS AG | |
| 25.11.14 | AstraZeneca Outperform | BNP PARIBAS | |
| 24.11.14 | Nokia buy | Citigroup Corp. | |
| 21.11.14 | Nokia Halten | Independent Research GmbH | |
| 21.11.14 | Volvo (B) Sell | S&P Capital IQ | |
| 19.11.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
| 19.11.14 | AstraZeneca buy | Citigroup Corp. | |
| 18.11.14 | AstraZeneca buy | UBS AG | |
| 17.11.14 | Nokia Neutral | UBS AG | |
| 17.11.14 | Nokia overweight | JP Morgan Chase & Co. | |
| 17.11.14 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 17.11.14 | AstraZeneca neutral | Barclays Capital | |
| 15.11.14 | Nokia Sell | S&P Capital IQ | |
| 14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | Citigroup Corp. | |
| 14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Underweight | Barclays Capital | |
| 14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 14.11.14 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 13.11.14 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 13.11.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
| 11.11.14 | Volvo (B) Sell | Goldman Sachs Group Inc. | |
| 10.11.14 | AstraZeneca buy | Jefferies & Company Inc. | |
| 10.11.14 | Nokia overweight | JP Morgan Chase & Co. | |
| 07.11.14 | AstraZeneca neutral | Independent Research GmbH | |
| 07.11.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 06.11.14 | AstraZeneca Hold | S&P Capital IQ | |
| 04.11.14 | AstraZeneca buy | UBS AG | |
| 04.11.14 | Nokia Underperform | Bernstein Research | |
| 03.11.14 | AstraZeneca Hold | Deutsche Bank AG | |
| 31.10.14 | AstraZeneca buy | Citigroup Corp. |